Home / Forums / Regulatory Considerations / EMA provides recommendations on compassionate use of remdesivirThis topic has 0 replies, 1 voice, and was last updated 9 months, 2 weeks ago by J WC.EMA provides recommendations on compassionate use of remdesivir J WC April 6, 2020 at 6:01 amOn April 3, 2020, the EMA provided recommendations on compassionate use of remdesivir for COVID-19 patients who are not eligible for inclusion in clinical trials. https://www.ema.europa.eu/en/news/ema-provides-recommendations-compassionate-use-remdesivir-covid-19 You must be logged in to reply to this topic.Log In Username: Password: Keep me signed inLogin